BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

114 related articles for article (PubMed ID: 29395386)

  • 21. Immediate versus delayed prostatectomy and the fate of patients who progress to a higher risk disease on active surveillance.
    Mallya A; Senguttuvan-Karthikeyan V; Sivaraman A; Barret E; Galiano M; Cathala N; Mombet A; Prapotnich D; Sanchez-Salas R; Cathelineau X
    Actas Urol Esp (Engl Ed); 2019; 43(6):324-330. PubMed ID: 30928176
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Development of urologic de novo malignancies after renal transplantation.
    Hevia V; Gómez V; Díez Nicolás V; Alvarez S; Gómez Del Cañizo C; Galeano C; Gomis A; García-Sagredo JM; Marcen R; Burgos FJ
    Transplant Proc; 2014; 46(1):170-5. PubMed ID: 24507046
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Improved biochemical outcome with adjuvant radiotherapy after radical prostatectomy for prostate cancer with poor pathologic features.
    Vargas C; Kestin LL; Weed DW; Krauss D; Vicini FA; Martinez AA
    Int J Radiat Oncol Biol Phys; 2005 Mar; 61(3):714-24. PubMed ID: 15708249
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Laparoscopic radical prostatectomy in renal transplant recipients.
    Robert G; Elkentaoui H; Pasticier G; Couzi L; Merville P; Ravaud A; Ballanger P; Ferrière JM; Wallerand H
    Urology; 2009 Sep; 74(3):683-7. PubMed ID: 19589578
    [TBL] [Abstract][Full Text] [Related]  

  • 25. The role of salvage extended lymph node dissection in patients with rising PSA and PET/CT scan detected nodal recurrence of prostate cancer.
    Porres D; Pfister D; Thissen A; Kuru TH; Zugor V; Buettner R; Knuechel R; Verburg FA; Heidenreich A
    Prostate Cancer Prostatic Dis; 2017 Mar; 20(1):85-92. PubMed ID: 27824042
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Duration of Androgen Deprivation Therapy Influences Outcomes for Patients Receiving Radiation Therapy Following Radical Prostatectomy.
    Jackson WC; Schipper MJ; Johnson SB; Foster C; Li D; Sandler HM; Palapattu GS; Hamstra DA; Feng FY
    Eur Urol; 2016 Jan; 69(1):50-7. PubMed ID: 26004800
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Prostate cancer prior to solid organ transplantation: the Israel Penn International Transplant Tumor Registry experience.
    Woodle ES; Gupta M; Buell JF; Neff GW; Gross TG; First MR; Hanaway MJ; Trofe J
    Transplant Proc; 2005 Mar; 37(2):958-9. PubMed ID: 15848589
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Morbidity, perioperative outcomes and complications of robot-assisted radical prostatectomy in kidney transplant patients: A French multicentre study.
    Felber M; Drouin SJ; Grande P; Vaessen C; Parra J; Barrou B; Matillon X; Crouzet S; Leclerc Q; Rigaud J; Prudhomme T; Doumerc N; Bergerat S; Lang H; Laine C; Robert G; Gobert A; Granger B; Rouprêt M
    Urol Oncol; 2020 Jun; 38(6):599.e15-599.e21. PubMed ID: 31948931
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Obligatory information that a patient diagnosed of prostate cancer and candidate for an active surveillance protocol must know.
    Rubio-Briones J; Iborra I; Ramírez M; Calatrava A; Collado A; Casanova J; Domínguez-Escrig J; Gómez-Ferrer A; Ricós JV; Monrós JL; Dumont R; López-Guerrero JA; Salas D; Solsona E
    Actas Urol Esp; 2014 Nov; 38(9):559-65. PubMed ID: 24636075
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Diagnosis and treatment of prostate cancers in renal-transplant recipients.
    Cormier L; Lechevallier E; Barrou B; Benoit G; Bensadoun H; Boudjema K; Descottes JL; Doré B; Guy L; Malavaud B; Martin X; Patard JJ; Petit J; Salomon L
    Transplantation; 2003 Jan; 75(2):237-9. PubMed ID: 12548131
    [TBL] [Abstract][Full Text] [Related]  

  • 31. The Role of Prostate-specific Antigen Persistence After Radical Prostatectomy for the Prediction of Clinical Progression and Cancer-specific Mortality in Node-positive Prostate Cancer Patients.
    Bianchi L; Nini A; Bianchi M; Gandaglia G; Fossati N; Suardi N; Moschini M; Dell'Oglio P; Schiavina R; Montorsi F; Briganti A
    Eur Urol; 2016 Jun; 69(6):1142-8. PubMed ID: 26749093
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Prostate Cancer in Renal Transplant Recipients: Diagnosis and Treatment.
    Carvalho JA; Nunes P; Dinis PJ; Antunes H; Parada B; Marconi L; Moreira P; Roseiro A; Bastos C; Rolo F; Dias V; Figueiredo A
    Transplant Proc; 2017 May; 49(4):809-812. PubMed ID: 28457400
    [TBL] [Abstract][Full Text] [Related]  

  • 33. [EAU guidelines on prostate cancer. Part I: screening, diagnosis, and treatment of clinically localised disease].
    Heidenreich A; Bellmunt J; Bolla M; Joniau S; Mason M; Matveev V; Mottet N; Schmid HP; van der Kwast T; Wiegel T; Zattoni F
    Actas Urol Esp; 2011 Oct; 35(9):501-14. PubMed ID: 21757259
    [TBL] [Abstract][Full Text] [Related]  

  • 34. [Cytoreductive radical prostatectomy for prostate cancer with minimal osseous metastases: results of a first feasibility and case control study].
    Heidenreich A; Pfister D; Brehmer B; Porres D
    Urologe A; 2015 Jan; 54(1):14-21. PubMed ID: 25519996
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Prostate cancer in 432 men aged <50 years in the prostate-specific antigen era: a new outlook.
    Gielchinsky I; Chang J; Cusick T; Delprado W; Nguyen Q; Yuen C; Savdie R; Böhm M; Haynes AM; Scheltema MJ; Stricker PD
    BJU Int; 2018 Nov; 122 Suppl 5():35-41. PubMed ID: 30303599
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Active Surveillance for Prostate Cancer in a Real-life Cohort: Comparing Outcomes for PRIAS-eligible and PRIAS-ineligible Patients.
    Soeterik TFW; van Melick HHE; Dijksman LM; Biesma DH; Witjes JA; van Basten JA
    Eur Urol Oncol; 2018 Aug; 1(3):231-237. PubMed ID: 31102626
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Oncological, functional and perioperative outcomes in transplant patients after radical prostatectomy.
    Beyer B; Mandel P; Michl U; Pompe RS; Veleva V; Steuber T; Huland H; Graefen M; Tilki D
    World J Urol; 2016 Aug; 34(8):1101-5. PubMed ID: 26757719
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Management of Biochemical Recurrence after Primary Curative Treatment for Prostate Cancer: A Review.
    Artibani W; Porcaro AB; De Marco V; Cerruto MA; Siracusano S
    Urol Int; 2018; 100(3):251-262. PubMed ID: 29161715
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Robotic radical prostatectomy as the initial step in multimodal therapy for men with high-risk localised prostate cancer: initial experience of 160 men.
    Connolly SS; Cathcart PJ; Gilmore P; Kerger M; Crowe H; Peters JS; Murphy DG; Costello AJ
    BJU Int; 2012 Mar; 109(5):752-9. PubMed ID: 21992472
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Prostatectomy for localized prostate cancer to prepare for renal transplantation in end-stage renal disease patients.
    Tillou X; Chahwan C; Le Gal S; Bensadoun H; Doerfler A
    Ann Transplant; 2014 Nov; 19():569-75. PubMed ID: 25374252
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 6.